PRLD
Prelude Therapeutics Inc
3.80$
-3.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Prelude Therapeutics Inc (PRLD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -56 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -13 | -26 | -46 | -84 | -84 | -107 | -103 | -56 | |
| 0.1 | 0.4 | 0.5 | 0.9 | 1.3 | 1.2 | 1.8 | 1.3 | |
| 0.2 | 0.8 | 5.6 | 21 | 25 | 26 | 21 | 12 | |
| 0.2 | 0.9 | 5.6 | 24 | 29 | – | – | – | |
| 1.4 | 0.7 | 4.6 | 3.6 | 0.9 | -10 | 4.2 | 28 | |
| 0.5 | 0.8 | 0.6 | 2.3 | 3.0 | 3.5 | 0.8 | 0.1 | |
| -0.5 | -0.8 | -0.6 | -264 | 82 | -35 | 90 | 53 | |
| – | – | – | – | – | 0.0 | – | – | |
| -0.1 | -0.1 | -0.3 | 0.0 | – | 0.0 | -0.4 | -0.2 | |
| 18 | 30 | 246 | 165 | 0.8 | 136 | -0.1 | 25 | |
| 4.5 | 3.3 | 199 | -182 | -1.2 | -5.3 | -13 | 22 | |
| -13 | -26 | -47 | -86 | -87 | -111 | -104 | -56 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.